Pub Date : 2026-01-11DOI: 10.1016/j.bbalip.2026.159718
Yinze Shi , Liying Huang , Xueyang Yang , Jiaoyue Zhang , Lulu Chen
Gm15441, a long non-coding RNA antisense to thioredoxin interacting protein (TXNIP) mRNA, exhibits undefined roles in adipogenesis and insulin resistance. This study aimed to explore its functions and mechanisms in white adipose tissue (WAT). Gm15441 expression was assessed in 3T3-L1 cells and WAT of insulin-resistant mice. Stable Gm15441 overexpression and knockdown 3T3-L1 cell models were established, followed by differentiation induction and analysis of lipid accumulation and differentiation markers. A subcutaneous adipose-specific Gm15441 overexpression mouse model was fed high-fat diets (HFD) and evaluated for metabolic parameters, adipogenesis, and insulin signaling. Subcellular localization in vitro was determined via fluorescence in situ hybridization, while transcriptome sequencing, TXNIP expression analysis, and RNA-RNA pull-down assays were performed. Results showed that Gm15441 expression increased during cell differentiation and decreased in insulin-resistant WAT. Gm15441 overexpression promoted adipogenesis in vitro, while knockdown suppressed it. In HFD-fed mice, adipose-specific Gm15441 overexpression enhanced adipogenesis, reduced blood glucose, and improved insulin sensitivity. Although PPARγ expression increased with cell differentiation, Gm15441 probes did not pull down PPARγ mRNA. Conversely, TXNIP protein levels decreased in Gm15441-overexpressing cells without corresponding changes in mRNA levels, but Gm15441 probes successfully pulled down TXNIP mRNA. These results suggested that Gm15441 may promote adipogenesis and enhance insulin sensitivity by inhibiting TXNIP expression.
{"title":"Gm15441 improves adipogenesis and insulin sensitivity by TXNIP regulation in white adipose tissue","authors":"Yinze Shi , Liying Huang , Xueyang Yang , Jiaoyue Zhang , Lulu Chen","doi":"10.1016/j.bbalip.2026.159718","DOIUrl":"10.1016/j.bbalip.2026.159718","url":null,"abstract":"<div><div><em>Gm15441</em>, a long non-coding RNA antisense to thioredoxin interacting protein (TXNIP) mRNA, exhibits undefined roles in adipogenesis and insulin resistance. This study aimed to explore its functions and mechanisms in white adipose tissue (WAT). <em>Gm15441</em> expression was assessed in 3T3-L1 cells and WAT of insulin-resistant mice. Stable <em>Gm15441</em> overexpression and knockdown 3T3-L1 cell models were established, followed by differentiation induction and analysis of lipid accumulation and differentiation markers. A subcutaneous adipose-specific <em>Gm15441</em> overexpression mouse model was fed high-fat diets (HFD) and evaluated for metabolic parameters, adipogenesis, and insulin signaling. Subcellular localization in vitro was determined via fluorescence in situ hybridization, while transcriptome sequencing, TXNIP expression analysis, and RNA-RNA pull-down assays were performed. Results showed that <em>Gm15441</em> expression increased during cell differentiation and decreased in insulin-resistant WAT. <em>Gm15441</em> overexpression promoted adipogenesis in vitro, while knockdown suppressed it. In HFD-fed mice, adipose-specific <em>Gm15441</em> overexpression enhanced adipogenesis, reduced blood glucose, and improved insulin sensitivity. Although PPARγ expression increased with cell differentiation, <em>Gm15441</em> probes did not pull down PPARγ mRNA. Conversely, TXNIP protein levels decreased in <em>Gm15441</em>-overexpressing cells without corresponding changes in mRNA levels, but <em>Gm15441</em> probes successfully pulled down TXNIP mRNA. These results suggested that <em>Gm15441</em> may promote adipogenesis and enhance insulin sensitivity by inhibiting TXNIP expression.</div></div>","PeriodicalId":8815,"journal":{"name":"Biochimica et biophysica acta. Molecular and cell biology of lipids","volume":"1871 3","pages":"Article 159718"},"PeriodicalIF":3.3,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145965026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Yeast phosphatidylinositol transfer protein Pdr16 supports azole resistance independently of lipid droplets","authors":"Lucia Pokorná, Dana Tahotná, Rebeka Rusnáková, Zuzana Pevalová, Dominik Šťastný, Peter Griač","doi":"10.1016/j.bbalip.2026.159721","DOIUrl":"10.1016/j.bbalip.2026.159721","url":null,"abstract":"<div><div><ul><li><span>•</span><span><div>Pdr16p is a potential target for preventing the development of azole resistance in fungi.</div></span></li><li><span>•</span><span><div>The molecular mechanism by which Pdr16p supports azole resistance remains unclear.</div></span></li><li><span>•</span><span><div>Pdr16p predominantly localizes to lipid droplets (LDs) in yeast cells.</div></span></li><li><span>•</span><span><div>Neither the presence of LDs nor the localization of Pdr16p to LDs contributes to azole resistance in yeast.</div></span></li><li><span>•</span><span><div>Pdr16p may play a role in adjusting ergosterol biosynthesis in response to azole treatment.</div></span></li></ul></div></div>","PeriodicalId":8815,"journal":{"name":"Biochimica et biophysica acta. Molecular and cell biology of lipids","volume":"1871 2","pages":"Article 159721"},"PeriodicalIF":3.3,"publicationDate":"2026-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145965208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-10DOI: 10.1016/j.bbalip.2026.159719
Joan Bestard-Escalas , Olivia Sasportes , Hafsa Ameraoui , Mar González-Nicolau , Mireille Alhouayek , Giulio G. Muccioli
Inflammatory bowel diseases (IBD) are chronic inflammatory disorders of the gastrointestinal tract with a high impact on patients' quality of life.
The endocannabinoids 2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine (AEA) are important modulators of inflammation. Their metabolism by cyclooxygenase (COX)-2 produces prostaglandin glycerol esters (PG-Gs) and prostaglandin ethanolamides (PG-EAs) that are endogenous analogues of the arachidonic acid-derived prostaglandins. Several PG-G and PG-EA possess interesting biological properties, notably in the context of colitis as we reported for PGD2-G. However, while the properties of prostaglandins (such as PGE2) on epithelial cells in the context of colon inflammation are well described, the biological effects of PG-Gs and PG-EAs are unknown.
Here we used Caco-2 spheroids and mouse colon organoids to evaluate how PG-Gs and PG-EAs modulate three epithelial hallmarks of colitis, namely the epithelial barrier integrity, the production of cytokines, and the wound healing process. Importantly, we tested the corresponding prostaglandins in parallel.
When analyzing the effects of these prostanoids on the production of pro-inflammatory cytokines, we found that PGD2-G did decrease the production of TNFα and MCP-1 in activated Caco-2 spheroids. On colon organoids, PGE2-G modulated the levels of TNFα, MIP2α, and KC and improved the survival of colon organoids in a DSS-plating efficiency assay without affecting stem cell dynamics. Our results put forth differential effects for PG-Gs, PG-EAs and the corresponding prostaglandins, and suggest that PGE2-G could be an interesting lipid mediator in the context of colon epithelium inflammation.
{"title":"The endocannabinoid-derived prostaglandin glycerol esters and prostaglandin ethanolamides modulate intestinal epithelial hallmarks of colitis","authors":"Joan Bestard-Escalas , Olivia Sasportes , Hafsa Ameraoui , Mar González-Nicolau , Mireille Alhouayek , Giulio G. Muccioli","doi":"10.1016/j.bbalip.2026.159719","DOIUrl":"10.1016/j.bbalip.2026.159719","url":null,"abstract":"<div><div>Inflammatory bowel diseases (IBD) are chronic inflammatory disorders of the gastrointestinal tract with a high impact on patients' quality of life.</div><div>The endocannabinoids 2-arachidonoylglycerol (2-AG) and <em>N</em>-arachidonoylethanolamine (AEA) are important modulators of inflammation. Their metabolism by cyclooxygenase (COX)-2 produces prostaglandin glycerol esters (PG-Gs) and prostaglandin ethanolamides (PG-EAs) that are endogenous analogues of the arachidonic acid-derived prostaglandins. Several PG-G and PG-EA possess interesting biological properties, notably in the context of colitis as we reported for PGD<sub>2</sub>-G. However, while the properties of prostaglandins (such as PGE<sub>2</sub>) on epithelial cells in the context of colon inflammation are well described, the biological effects of PG-Gs and PG-EAs are unknown.</div><div>Here we used Caco-2 spheroids and mouse colon organoids to evaluate how PG-Gs and PG-EAs modulate three epithelial hallmarks of colitis, namely the epithelial barrier integrity, the production of cytokines, and the wound healing process. Importantly, we tested the corresponding prostaglandins in parallel.</div><div>When analyzing the effects of these prostanoids on the production of pro-inflammatory cytokines, we found that PGD<sub>2</sub>-G did decrease the production of TNFα and MCP-1 in activated Caco-2 spheroids. On colon organoids, PGE<sub>2</sub>-G modulated the levels of TNFα, MIP2α, and KC and improved the survival of colon organoids in a DSS-plating efficiency assay without affecting stem cell dynamics. Our results put forth differential effects for PG-Gs, PG-EAs and the corresponding prostaglandins, and suggest that PGE<sub>2</sub>-G could be an interesting lipid mediator in the context of colon epithelium inflammation.</div></div>","PeriodicalId":8815,"journal":{"name":"Biochimica et biophysica acta. Molecular and cell biology of lipids","volume":"1871 2","pages":"Article 159719"},"PeriodicalIF":3.3,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-08DOI: 10.1016/j.bbalip.2026.159717
Chisom J. Onu , Michael Adu , Gil-Soo Han , George M. Carman , Miriam L. Greenberg
Valproic acid (VPA) is a widely prescribed mood stabilizer used in the pharmacological management of bipolar disorder (BD), a psychiatric illness that affects 2% of the world's population. Although VPA has been in use for four decades, the therapeutic mechanism of action has not been determined. Inositol depletion is a proposed mechanism, but how VPA depletes inositol is not understood. Using the yeast model, in which the inositol biosynthetic pathway has been well characterized, we show that VPA supplementation leads to decreased levels of phosphatidic acid (PA), including decreased PA species 34:1. Supplementation with PA 34:1 or increasing PA levels by deletion of PAH1 partially rescued VPA-induced repression of INO1. VPA-mediated repression is mediated by the Opi1-Ino2 interaction, as INO1 expression is not repressed in an Ino2 mutant that does not bind to Opi1. The central role of PA in VPA-mediated repression has implications for the mechanism of action of VPA in mammalian cells.
{"title":"Valproate causes inositol depletion in yeast by decreasing levels of phosphatidic acid and increasing Opi1-mediated repression of INO1 expression","authors":"Chisom J. Onu , Michael Adu , Gil-Soo Han , George M. Carman , Miriam L. Greenberg","doi":"10.1016/j.bbalip.2026.159717","DOIUrl":"10.1016/j.bbalip.2026.159717","url":null,"abstract":"<div><div>Valproic acid (VPA) is a widely prescribed mood stabilizer used in the pharmacological management of bipolar disorder (BD), a psychiatric illness that affects 2% of the world's population. Although VPA has been in use for four decades, the therapeutic mechanism of action has not been determined. Inositol depletion is a proposed mechanism, but how VPA depletes inositol is not understood. Using the yeast model, in which the inositol biosynthetic pathway has been well characterized, we show that VPA supplementation leads to decreased levels of phosphatidic acid (PA), including decreased PA species 34:1. Supplementation with PA 34:1 or increasing PA levels by deletion of <em>PAH1</em> partially rescued VPA-induced repression of <em>INO1</em>. VPA-mediated repression is mediated by the Opi1-Ino2 interaction, as <em>INO1</em> expression is not repressed in an Ino2 mutant that does not bind to Opi1. The central role of PA in VPA-mediated repression has implications for the mechanism of action of VPA in mammalian cells.</div></div>","PeriodicalId":8815,"journal":{"name":"Biochimica et biophysica acta. Molecular and cell biology of lipids","volume":"1871 2","pages":"Article 159717"},"PeriodicalIF":3.3,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145920933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-06DOI: 10.1016/j.bbalip.2026.159716
Mohamed Fouad Mansour , Amany Behairy , Tarek khamis , Haiam A. Mohammed , Amira Ebrahim Alsemeh , Asmaa Monir Eltaweel , Mahran Mohamed Abd El-Emam
Dyslipidemia is a major risk factor for the development of atherosclerosis, cardiovascular diseases, and brain injury. Berberine (BER), a type of isoquinoline alkaloid, has the potential to enhance mitochondrial performance owing to its remarkable antioxidant properties. This study aimed to explore how berberine-loaded niosomes (BER-NIO) would alleviate the adverse effects of brain injury in dyslipidemic rats. Hence, for this purpose, the genes of electron transport chain, mitochondrial dynamics, mitophagy, and apoptosis were assessed in brain tissue. Moreover, molecular docking analysis was done to predict this target pathway.
Methods
Thirty-five male Sprague Dawley rats were separated into five groups: (I) Control (Ctl), (II) Poloxamer 407 (Plx), (III) Plx + BER-NIO, (IV) Plx + NC, and (V) Plx + BER-NIO + NC.
Results
BER-NIO improved lipid profile, brain MDA, and brain total antioxidant capacity (TAC) compared to Plx group. Moreover, BER-NIO was able to notably restore the activity of mitochondrial respiratory chain complexes through upregulation of the mRNA expression levels of Ndufs1, Sdhc, Coq8a, Cox6a2 and Atp5f1a. It also enhanced the mitochondrial dynamics via modulation of the transcriptional level of DRP-1, MFN-1, and MFN-2. In addition, administration of BER-NIO to dyslipidemic rats regulated the mitophagy pathway through alteration of PINK-1/Prkn pathway within brain tissue. Furthermore, BER-NIO notably enhanced neurological function through reduction of brain pathological alterations, suppression of apoptosis and decrease of the biomarker for brain injury (GFAP). Interestingly, molecular docking analysis revealed a strong binding affinity between BER and MFN-2, PINK-1 and caspase-3.
Conclusion
The findings suggested that the BER-NIO is effective in the reduction of brain injury in dyslipidemic rats via modulation of brain oxidant/antioxidant status and mitochondrial functions.
{"title":"Neuroprotective effect of berberine-loaded niosomes against brain injury in dyslipidemic rats: The interplay between oxidative stress, mitochondrial dysfunction and apoptotic signals","authors":"Mohamed Fouad Mansour , Amany Behairy , Tarek khamis , Haiam A. Mohammed , Amira Ebrahim Alsemeh , Asmaa Monir Eltaweel , Mahran Mohamed Abd El-Emam","doi":"10.1016/j.bbalip.2026.159716","DOIUrl":"10.1016/j.bbalip.2026.159716","url":null,"abstract":"<div><div>Dyslipidemia is a major risk factor for the development of atherosclerosis, cardiovascular diseases, and brain injury. Berberine (BER), a type of isoquinoline alkaloid, has the potential to enhance mitochondrial performance owing to its remarkable antioxidant properties. This study aimed to explore how berberine-loaded niosomes (BER-NIO) would alleviate the adverse effects of brain injury in dyslipidemic rats. Hence, for this purpose, the genes of electron transport chain, mitochondrial dynamics, mitophagy, and apoptosis were assessed in brain tissue. Moreover, molecular docking analysis was done to predict this target pathway.</div></div><div><h3>Methods</h3><div>Thirty-five male Sprague Dawley rats were separated into five groups: (I) Control (Ctl), (II) Poloxamer 407 (Plx), (III) Plx + BER-NIO, (IV) Plx + NC, and (V) Plx + BER-NIO + NC.</div></div><div><h3>Results</h3><div>BER-NIO improved lipid profile, brain MDA, and brain total antioxidant capacity (TAC) compared to Plx group. Moreover, BER-NIO was able to notably restore the activity of mitochondrial respiratory chain complexes through upregulation of the mRNA expression levels of Ndufs1, Sdhc, Coq8a, Cox6a2 and Atp5f1a. It also enhanced the mitochondrial dynamics via modulation of the transcriptional level of DRP-1, MFN-1, and MFN-2. In addition, administration of BER-NIO to dyslipidemic rats regulated the mitophagy pathway through alteration of PINK-1/Prkn pathway within brain tissue. Furthermore, BER-NIO notably enhanced neurological function through reduction of brain pathological alterations, suppression of apoptosis and decrease of the biomarker for brain injury (GFAP). Interestingly, molecular docking analysis revealed a strong binding affinity between BER and MFN-2, PINK-1 and caspase-3.</div></div><div><h3>Conclusion</h3><div>The findings suggested that the BER-NIO is effective in the reduction of brain injury in dyslipidemic rats via modulation of brain oxidant/antioxidant status and mitochondrial functions.</div></div>","PeriodicalId":8815,"journal":{"name":"Biochimica et biophysica acta. Molecular and cell biology of lipids","volume":"1871 2","pages":"Article 159716"},"PeriodicalIF":3.3,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145931438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-05DOI: 10.1016/j.bbalip.2026.159715
Liming Tian , Guan Wang , Shuhong Zhang , Zhaohua He , Fangfang Zhao , Menghan Chang , Wei Han , Dandan Ye , Shaobin Li , Guangli Yang
Fat deposition represents a fundamental physiological process in mammalian energy metabolism, yet its molecular regulatory mechanisms remain incompletely understood. Adipocytes, the primary site of fat storage, develop through proliferation and differentiation of preadipocytes—a process controlled by multiple molecular regulators. MicroRNAs (miRNAs) act as crucial post-transcriptional regulators and play an essential role in mammalian adipogenesis. However, their specific functions in ovine tail fat deposition remain poorly characterized. This study aimed to systematically investigate the regulatory role of miR-432 in adipogenesis using sheep tail fat as a model system. Through establishing an in vitro preadipocyte culture model and implementing gain- and loss-of-function approaches via miRNA overexpression and antisense oligonucleotide inhibition, we demonstrated that elevated expression of miR-432 significantly enhanced preadipocyte proliferation, accompanied by upregulation of proliferation-related genes (Cyclin D, PCNA). However, it decreased lipid droplet accumulation and reduced the expression of differentiation markers (PPARγ, FABP4). Conversely, inhibition of miR-432 reduced cellular proliferation, downregulated key cell cycle genes (CCNB1, Cyclin B3), and enhanced adipogenic differentiation, as evidenced by increased lipid droplet formation and elevated expression of adipogenic genes (PPARγ, Adiponectin, FABP4). These findings demonstrate that miR-432 exerts a dual regulatory role in sheep tail adipogenesis by modulating both proliferative and differentiative processes in adipocytes. This research provides novel molecular insights into the regulatory mechanisms underlying fat deposition.
{"title":"MiR-432 mediates bidirectional regulation in the determination of adipocyte fate","authors":"Liming Tian , Guan Wang , Shuhong Zhang , Zhaohua He , Fangfang Zhao , Menghan Chang , Wei Han , Dandan Ye , Shaobin Li , Guangli Yang","doi":"10.1016/j.bbalip.2026.159715","DOIUrl":"10.1016/j.bbalip.2026.159715","url":null,"abstract":"<div><div>Fat deposition represents a fundamental physiological process in mammalian energy metabolism, yet its molecular regulatory mechanisms remain incompletely understood. Adipocytes, the primary site of fat storage, develop through proliferation and differentiation of preadipocytes—a process controlled by multiple molecular regulators. MicroRNAs (miRNAs) act as crucial post-transcriptional regulators and play an essential role in mammalian adipogenesis. However, their specific functions in ovine tail fat deposition remain poorly characterized. This study aimed to systematically investigate the regulatory role of miR-432 in adipogenesis using sheep tail fat as a model system. Through establishing an in vitro preadipocyte culture model and implementing gain- and loss-of-function approaches via miRNA overexpression and antisense oligonucleotide inhibition, we demonstrated that elevated expression of miR-432 significantly enhanced preadipocyte proliferation, accompanied by upregulation of proliferation-related genes (<em>Cyclin D</em>, <em>PCNA</em>). However, it decreased lipid droplet accumulation and reduced the expression of differentiation markers (<em>PPARγ</em>, <em>FABP4</em>). Conversely, inhibition of miR-432 reduced cellular proliferation, downregulated key cell cycle genes (<em>CCNB1</em>, <em>Cyclin B3</em>), and enhanced adipogenic differentiation, as evidenced by increased lipid droplet formation and elevated expression of adipogenic genes (<em>PPARγ</em>, <em>Adiponectin</em>, <em>FABP4</em>). These findings demonstrate that miR-432 exerts a dual regulatory role in sheep tail adipogenesis by modulating both proliferative and differentiative processes in adipocytes. This research provides novel molecular insights into the regulatory mechanisms underlying fat deposition.</div></div>","PeriodicalId":8815,"journal":{"name":"Biochimica et biophysica acta. Molecular and cell biology of lipids","volume":"1871 2","pages":"Article 159715"},"PeriodicalIF":3.3,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145917025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-18DOI: 10.1016/j.bbalip.2025.159714
Shamshad Cockcroft
This retrospective traces the evolution of our understanding of the phosphatidylinositol transfer protein (PITP) family over the past fifty years, beginning with its purification. I summarise the early identification of PITPs as phosphatidylinositol/phosphatidylcholine (PI/PC) transfer proteins and describe how the conserved PITP domain was subsequently recognised in five mammalian proteins, occurring either as a single domain or within a multi-domain architecture. Parallel genetic studies in Drosophila led to the discovery of RdgB, a retinal degeneration mutant protein containing a PITP domain. Later work revealed that some members of the PITP family members mediate PI/PA (phosphatidate) exchange enabling the reciprocal transfer of PA and PI during phospholipase C (PLC) signalling. PITPs thus function as key lipid exchangers, delivering PI for synthesis of phosphorylated derivatives including phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2) across cellular compartments. These activities position PITPs at the core of fundamental processes such as PLC signalling and Golgi membrane trafficking, where phosphoinositides play central regulatory roles. Finally, I highlight how PITPs have emerged as critical factors in diverse physiological processes and as contributors to a growing range of pathological conditions.
{"title":"A retrospective on phosphatidylinositol transfer proteins (PITPs) – A fifty-year journey","authors":"Shamshad Cockcroft","doi":"10.1016/j.bbalip.2025.159714","DOIUrl":"10.1016/j.bbalip.2025.159714","url":null,"abstract":"<div><div>This retrospective traces the evolution of our understanding of the phosphatidylinositol transfer protein (PITP) family over the past fifty years, beginning with its purification. I summarise the early identification of PITPs as phosphatidylinositol/phosphatidylcholine (PI/PC) transfer proteins and describe how the conserved PITP domain was subsequently recognised in five mammalian proteins, occurring either as a single domain or within a multi-domain architecture. Parallel genetic studies in <em>Drosophila</em> led to the discovery of RdgB, a retinal degeneration mutant protein containing a PITP domain. Later work revealed that some members of the PITP family members mediate PI/PA (phosphatidate) exchange enabling the reciprocal transfer of PA and PI during phospholipase C (PLC) signalling. PITPs thus function as key lipid exchangers, delivering PI for synthesis of phosphorylated derivatives including phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P<sub>2</sub>) across cellular compartments. These activities position PITPs at the core of fundamental processes such as PLC signalling and Golgi membrane trafficking, where phosphoinositides play central regulatory roles. Finally, I highlight how PITPs have emerged as critical factors in diverse physiological processes and as contributors to a growing range of pathological conditions.</div></div>","PeriodicalId":8815,"journal":{"name":"Biochimica et biophysica acta. Molecular and cell biology of lipids","volume":"1871 2","pages":"Article 159714"},"PeriodicalIF":3.3,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-13DOI: 10.1016/j.bbalip.2025.159711
Mi Tang , Jianghui Cai , Ling Zhang , Liling xiong , Xuejia Gong , Jinzhu Fu , Peilin Wang , Mengqiu Luo , Hong Liu , Ying Ye , Min Yu , Heng Yu , ShaSha Xing , Xiao Yang
Introduction
Intrahepatic cholestasis of pregnancy (ICP) is a disorder characterized by maternal pruritus and elevated total bile acid concentrations during pregnancy, posing severe fetal risks associated with placental dysfunction. However, the mechanisms underlying ICP remain to be fully elucidated.
Methods
An integrated approach was employed, utilizing placental scRNA-seq, LC-MS/MS-based lipidomics, and public RNA-seq data. The AUCell package, PPI network analysis, Random Forest, Support Vector Machine, and LASSO regression analyses were utilized to explore mitochondrial functions and identify hub mitochondria-related genes (MRGs). KEGG, GSEA, and GSVA were employed to investigate potential biological mechanisms. Key findings were validated by immunohistochemistry, immunofluorescence, and western blotting. Reactive oxygen species (ROS), malondialdehyde (MDA) and transmission electron microscopy were utilized to evaluate oxidative stress levels, lipid peroxidation and conduct ultrastructural examinations of mitochondria, respectively.
Results
MRGs are primarily distributed in villous cytotrophoblast (VCT). KEGG analysis of VCT indicated a close association with oxidative phosphorylation, ROS, Lipid. ACADVL was identified as a hub MRG and was found increased in ICP placenta, particularly in VCT. Functional analysis of ACADVLhigh VCT revealed enrichment in fatty acid metabolism and oxidative phosphorylation. Lipidomics identified substantial alterations in glycerophospholipid and glycerolipid metabolism, and polyunsaturated fatty acid (PUFA) metabolism pathways. Experimentally, we observed the mitochondrial ACADVL localization, increased DRP1, decreased MFN2 and GPX4, and increased ROS and MDA levels in ICP. Electron microscopy revealed ultrastructural features consistent with ferroptosis.
Conclusion
This study proposes a novel model linking ACADVL, lipid metabolism, mitochondrial dysfunction, and ferroptosis in ICP pathogenesis.
{"title":"ACADVL upregulation is associated with placental ferroptosis in intrahepatic cholestasis of pregnancy","authors":"Mi Tang , Jianghui Cai , Ling Zhang , Liling xiong , Xuejia Gong , Jinzhu Fu , Peilin Wang , Mengqiu Luo , Hong Liu , Ying Ye , Min Yu , Heng Yu , ShaSha Xing , Xiao Yang","doi":"10.1016/j.bbalip.2025.159711","DOIUrl":"10.1016/j.bbalip.2025.159711","url":null,"abstract":"<div><h3>Introduction</h3><div>Intrahepatic cholestasis of pregnancy (ICP) is a disorder characterized by maternal pruritus and elevated total bile acid concentrations during pregnancy, posing severe fetal risks associated with placental dysfunction. However, the mechanisms underlying ICP remain to be fully elucidated.</div></div><div><h3>Methods</h3><div>An integrated approach was employed, utilizing placental scRNA-seq, LC-MS/MS-based lipidomics, and public RNA-seq data. The AUCell package, PPI network analysis, Random Forest, Support Vector Machine, and LASSO regression analyses were utilized to explore mitochondrial functions and identify hub mitochondria-related genes (MRGs). KEGG, GSEA, and GSVA were employed to investigate potential biological mechanisms. Key findings were validated by immunohistochemistry, immunofluorescence, and western blotting. Reactive oxygen species (ROS), malondialdehyde (MDA) and transmission electron microscopy were utilized to evaluate oxidative stress levels, lipid peroxidation and conduct ultrastructural examinations of mitochondria, respectively.</div></div><div><h3>Results</h3><div>MRGs are primarily distributed in villous cytotrophoblast (VCT). KEGG analysis of VCT indicated a close association with oxidative phosphorylation, ROS, Lipid. ACADVL was identified as a hub MRG and was found increased in ICP placenta, particularly in VCT. Functional analysis of ACADVL<sup>high</sup> VCT revealed enrichment in fatty acid metabolism and oxidative phosphorylation. Lipidomics identified substantial alterations in glycerophospholipid and glycerolipid metabolism, and polyunsaturated fatty acid (PUFA) metabolism pathways. Experimentally, we observed the mitochondrial ACADVL localization, increased DRP1, decreased MFN2 and GPX4, and increased ROS and MDA levels in ICP. Electron microscopy revealed ultrastructural features consistent with ferroptosis.</div></div><div><h3>Conclusion</h3><div>This study proposes a novel model linking ACADVL, lipid metabolism, mitochondrial dysfunction, and ferroptosis in ICP pathogenesis.</div></div>","PeriodicalId":8815,"journal":{"name":"Biochimica et biophysica acta. Molecular and cell biology of lipids","volume":"1871 2","pages":"Article 159711"},"PeriodicalIF":3.3,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-12DOI: 10.1016/j.bbalip.2025.159713
Izabela Burzynska-Pedziwiatr , Malgorzata Bukowiecka-Matusiak , Barbara Pacholczyk-Sienicka , Katarzyna Cypryk , Monika Zurawska-Klis , Andrzej Zieleniak , Lukasz Albrecht , Lucyna A. Wozniak
The lipid abnormalities are observed in pregnant women with normal glucose tolerance (NGT) and those diagnosed with gestational diabetes mellitus (GDM), but in the latter, they are intensified and may indicate underlying metabolic dysfunction that transiently manifests during pregnancy. Due to the complex relationship between lipid metabolism and glucose regulation, alterations in lipoproteins may act as preliminary biomarkers for the early detection and monitoring of GDM and postpartum changes.
In the current study, we performed a 1H NMR analysis of plasma lipoproteins in the cohort comprising pregnant NGT women and those diagnosed with GDM at three critical time points: 24–28 gestation week and 3 and 12 months postpartum.
After assignment of lipoprotein-associated signals in NMR spectra, Partial Least Squares Discriminant Analysis (PLS-DA) revealed clear distinctions between NGT and GDM groups.
Correlation analysis revealed a moderate negative correlation of CH3VLDL, a moderate positive correlations of CH2CH2C=C with 2 h-OGTT and 1 h-OGTT, and a significant negative correlation of CH3VLDL, and a positive correlation of CH2CH2C=C were noted for HOMA IR.
At the 3-months mark, the concentrations of (CH2)n LDL, CH2CH2CH2CO VLDL, all unsaturated lipids, and (CH=CH) LDL + VLDL, CH2/CH3 LDL + VLDL, and CH=CH/CH3 LDL + VLDL were decreased, while the concentrations of (C18 VLDL, CH3 LDL, CH2CH2C=C, CH2C=C, CH2CO, C=CCH2C=C, choline N(CH3)3, glyceryl CH2OCOR) were increased. The concentrations of selected fractions at the 1-year postpartum time point remained unchanged.
Our findings provide essential insights into lipoprotein dysregulation in GDM and underscore possible implications for early intervention and long-term metabolic risk reduction for maternal health.
{"title":"1H NMR studies of alterations in lipoprotein profiles in women diagnosed with gestational diabetes mellitus (GDM) and after delivery","authors":"Izabela Burzynska-Pedziwiatr , Malgorzata Bukowiecka-Matusiak , Barbara Pacholczyk-Sienicka , Katarzyna Cypryk , Monika Zurawska-Klis , Andrzej Zieleniak , Lukasz Albrecht , Lucyna A. Wozniak","doi":"10.1016/j.bbalip.2025.159713","DOIUrl":"10.1016/j.bbalip.2025.159713","url":null,"abstract":"<div><div>The lipid abnormalities are observed in pregnant women with normal glucose tolerance (NGT) and those diagnosed with gestational diabetes mellitus (GDM), but in the latter, they are intensified and may indicate underlying metabolic dysfunction that transiently manifests during pregnancy. Due to the complex relationship between lipid metabolism and glucose regulation, alterations in lipoproteins may act as preliminary biomarkers for the early detection and monitoring of GDM and postpartum changes.</div><div>In the current study, we performed a <sup>1</sup>H NMR analysis of plasma lipoproteins in the cohort comprising pregnant NGT women and those diagnosed with GDM at three critical time points: 24–28 gestation week and 3 and 12 months postpartum.</div><div>After assignment of lipoprotein-associated signals in NMR spectra, Partial Least Squares Discriminant Analysis (PLS-DA) revealed clear distinctions between NGT and GDM groups.</div><div>Correlation analysis revealed a moderate negative correlation of CH<sub>3</sub>VLDL, a moderate positive correlations of CH<sub>2</sub>CH<sub>2</sub>C=C with 2 h-OGTT and 1 h-OGTT, and a significant negative correlation of CH<sub>3</sub>VLDL, and a positive correlation of CH<sub>2</sub>CH<sub>2</sub>C=C were noted for HOMA IR.</div><div>At the 3-months mark, the concentrations of (CH<sub>2</sub>)<sub>n</sub> LDL, CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CO VLDL, all unsaturated lipids, and (CH=CH) LDL + VLDL, CH<sub>2</sub>/CH<sub>3</sub> LDL + VLDL, and CH=CH/CH<sub>3</sub> LDL + VLDL were decreased, while the concentrations of (C18 VLDL, CH<sub>3</sub> LDL, CH<sub>2</sub>CH<sub>2</sub>C=C, CH<sub>2</sub>C=C, CH<sub>2</sub>CO, C=CCH<sub>2</sub>C=C, choline N(CH<sub>3</sub>)<sub>3</sub>, glyceryl CH<sub>2</sub>OCOR) were increased. The concentrations of selected fractions at the 1-year postpartum time point remained unchanged.</div><div>Our findings provide essential insights into lipoprotein dysregulation in GDM and underscore possible implications for early intervention and long-term metabolic risk reduction for maternal health.</div></div>","PeriodicalId":8815,"journal":{"name":"Biochimica et biophysica acta. Molecular and cell biology of lipids","volume":"1871 2","pages":"Article 159713"},"PeriodicalIF":3.3,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145755153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-11DOI: 10.1016/j.bbalip.2025.159710
Na Wei , Wanyu Feng , Meijun Pan , Xinyi Xu , Shuguo Zheng , Huanhuan Jin
Curcumol, a bioactive constituent derived from Rhizoma Curcumae roots, possesses anti-inflammatory and anti-viral properties. This study investigated its therapeutic effects on lipophagy in hepatic stellate cells (HSCs) and lipid accumulation in hepatocytes within a model of high-fat diet-induced hepatic fibrosis, along with the underlying molecular mechanisms. Initially, curcumol treatment significantly attenuated lipid droplets (LDs) degradation and suppressed HSC activation, effects potentially associated with the inhibition of lipophagy. These outcomes were partially reversed by Rab18 overexpression, which modulates the autophagy-lysosomal pathway. Moreover, the ameliorative effect of curcumol on choline-deficient, L-amino acid-defined, 45 % high-fat diet (CDAHFD)-induced hepatic pathology was partially abolished upon Rab18 overexpression in mice. Importantly, curcumol promoted Farnesoid X receptor (FXR) expression, which inhibited the CREB/TORC2 interaction, thereby further suppressing LC3B expression and activation in LX2 cells. Additionally, curcumol impeded LD expansion and reduced lipid accumulation in palmitic acid (PA)-treated BNL-CL.2 cells and hepatocytes from CDAHFD-fed mice by inhibiting LD–endoplasmic reticulum (ER) contact formation, which could be reversed by Rab18 overexpression. In conclusion, curcumol inhibits HSC lipophagy by downregulating Rab18-mediated LD–autophagosome formation and enhancing the FXR–CREB interaction. Furthermore, it ameliorates hepatocyte lipid accumulation in fibrotic livers by disrupting Rab18-dependent LD–ER contacts. These findings underscore the therapeutic potential of curcumol in the treatment of HFD-induced hepatic fibrosis.
{"title":"Curcumol ameliorates high-fat diet-induced hepatic fibrosis via dual regulation of FXR-CREB and Rab18-mediated hepatic stellate cell lipophagy","authors":"Na Wei , Wanyu Feng , Meijun Pan , Xinyi Xu , Shuguo Zheng , Huanhuan Jin","doi":"10.1016/j.bbalip.2025.159710","DOIUrl":"10.1016/j.bbalip.2025.159710","url":null,"abstract":"<div><div>Curcumol, a bioactive constituent derived from <em>Rhizoma Curcumae</em> roots, possesses anti-inflammatory and anti-viral properties. This study investigated its therapeutic effects on lipophagy in hepatic stellate cells (HSCs) and lipid accumulation in hepatocytes within a model of high-fat diet-induced hepatic fibrosis, along with the underlying molecular mechanisms. Initially, curcumol treatment significantly attenuated lipid droplets (LDs) degradation and suppressed HSC activation, effects potentially associated with the inhibition of lipophagy. These outcomes were partially reversed by Rab18 overexpression, which modulates the autophagy-lysosomal pathway. Moreover, the ameliorative effect of curcumol on choline-deficient, L-amino acid-defined, 45 % high-fat diet (CDAHFD)-induced hepatic pathology was partially abolished upon Rab18 overexpression in mice. Importantly, curcumol promoted Farnesoid X receptor (FXR) expression, which inhibited the CREB/TORC2 interaction, thereby further suppressing LC3B expression and activation in LX2 cells. Additionally, curcumol impeded LD expansion and reduced lipid accumulation in palmitic acid (PA)-treated BNL-CL.2 cells and hepatocytes from CDAHFD-fed mice by inhibiting LD–endoplasmic reticulum (ER) contact formation, which could be reversed by Rab18 overexpression. In conclusion, curcumol inhibits HSC lipophagy by downregulating Rab18-mediated LD–autophagosome formation and enhancing the FXR–CREB interaction. Furthermore, it ameliorates hepatocyte lipid accumulation in fibrotic livers by disrupting Rab18-dependent LD–ER contacts. These findings underscore the therapeutic potential of curcumol in the treatment of HFD-induced hepatic fibrosis.</div></div>","PeriodicalId":8815,"journal":{"name":"Biochimica et biophysica acta. Molecular and cell biology of lipids","volume":"1871 2","pages":"Article 159710"},"PeriodicalIF":3.3,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145751467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}